Platinum-based drugs disrupt STAT6-mediated suppression of immune responses against cancer in humans and mice
Tumor microenvironments feature immune inhibitory mechanisms that prevent T cells from generating effective antitumor immune responses. Therapeutic interventions aimed at disrup...